Clinical Trials on Congenital+Rubella

Total 8870 results

PT Bio Farma

Completed

Immunogenicity & Safety of Bio Farma's Measles-Rubella (MR) Vaccine in Indonesian Infants (Bridging Study)

Measles | Congenital Rubella Infection

Indonesia
Centers for Disease Control and Prevention
International Centre for Diarrhoeal Disease Research, Bangladesh; Ministry...

Completed

Measles-Rubella Vaccine Immunogenicity at 6 and 9 Months of Age

Measles | Rubella | Rubella Syndrome, Congenital

Bangladesh
Takeda

Completed

Freeze-dried Live Attenuated Measles/Rubella Combined Vaccine (Schwarz FF-8 Strain/TO-336 Strain) Specified Drug-use Survey of Vaccinees After the Second Vaccination

Measles/Rubella

Japan
Rigshospitalet, Denmark

Completed

MMR at 6 Months Trial

Meales-mumps-rubella Vaccine

Denmark
University of Rochester

Completed

MMR and Varicella Vaccine in Premature Infants

Rubella | Mumps | Chickenpox | Rubeola

United States
Takeda

Completed

Freeze-dried Live Attenuated Measles/Rubella Combined Vaccine (Schwarz FF-8 Strain/TO-336 Strain) Special Drug Use Surveillance of Vaccinees After the First Vaccination

Measles/Rubella
GlaxoSmithKline

Completed

Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' Measles, Mumps and Rubella (MMR) Vaccine (209762) Compared to Merck & Co., Inc.'s MMR Vaccine in Healthy Children 12 to 15 Months of Age

Measles; Mumps; Rubella | Measles-Mumps-Rubella Vaccine

United States, Finland, Taiwan, Estonia, Puerto Rico
PATH

Completed

Coadministration of Measles-rubella and Rotavirus Vaccines

Measles Antibody Seroconversion | Rubella Antibody Seroconversion | Rotavirus Geometric Mean Titer (GMT) | Rotavirus Immunoglobulin A (IgA) Seropositivity

Bangladesh
GlaxoSmithKline

Completed

Immunogenicity of GSKs' MMR Vaccine (209762) vs. M-M-R® II, When Given With Routine Vaccines at 12-15 Months of Age

Measles | Rubella | Mumps | Measles-Mumps-Rubella Vaccine

United States, Puerto Rico
GlaxoSmithKline

Completed

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Combined Measles-mumps-rubella (MMR) Vaccine in Children in Their Second Year of Life

Measles | Rubella | Mumps | Measles-Mumps-Rubella Vaccine

Finland, Thailand, United States, Spain, Czechia, Puerto Rico, Malaysia
GlaxoSmithKline

Completed

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Combined Measles-mumps-rubella (MMR) Vaccine in Subjects Four to Six Years of Age

Measles-Mumps-Rubella

Taiwan, United States, Korea, Republic of
Hopital Foch

Completed

Study of Rubella Immunity. Response to Vaccination of Subjects With Very Low, Equivocal or Undetectable Titers of Rubella Virus Antibodies (ImmRubVac)

Pregnancy

France
Unity Health Toronto

Completed

Rubella Susceptibility in Multiparous Women

Rubella | Vaccine

Canada
University of Alberta

Withdrawn

Initiation of Resuscitation While Attached to the Cord With Congenital Heart Disease (INSPIRE-CHD)

Hypoplastic Left Heart Syndrome | Congenital Heart Defect | TGA - Transposition of Great Arteries | Congential Absence of Heart Structure | Congenital Malformation of Heart, Unspecified | Hypoplastic Right Heart Syndrome | Congential Malformations of Aortic Valve | Congential Malformations of Great...

Canada
GlaxoSmithKline

Recruiting

A Study on the Immune Response and Safety of a Combined Measles, Mumps, Rubella, Chickenpox Vaccine Compared to a Marketed Combined Vaccine, Given to Healthy Children 4 to 6 Years of Age

Measles; Mumps; Rubella; Chickenpox

United States
Merck Sharp & Dohme LLC

Completed

ProQuad® Intramuscular vs Subcutaneous

Measles | Rubella | Mumps | Varicella
Merck Sharp & Dohme LLC

Completed

Safety, Tolerability, and Immunogenicity of an Investigational Vaccine With Recombinant Human Albumin (rHA) in Children 12 to 18 Months of Age (V205C-009)(COMPLETED)

Measles | Rubella | Mumps | Varicella
Shanghai Institute Of Biological Products

Completed

Clinical Trial of Measles, Mumps and Rubella Combined Vaccine, Live

Vaccine | Immunotoxicity

China
The Immunobiological Technology Institute (Bio-Manguinhos)...
Bill and Melinda Gates Foundation

Completed

Study to Evaluate Safety and Imunogenicity of Double Viral Vaccine (MR) for Measles and Rubella (MR)

Measles | Rubella

Brazil
Merck Sharp & Dohme LLC

Completed

Frozen ProQuad Administered Concomitantly Versus Nonconcomitantly With Other Pediatric Vaccines

Measles | Rubella | Mumps | Varicella
The Immunobiological Technology Institute (Bio-Manguinhos)...
Oswaldo Cruz Institute

Completed

Study to Evaluate the Immunogenicity, Reatogenicity and Safety of Double Viral Vaccine (MR) for Measles and Rubella (BIOMR)

Measles | Rubella

Brazil
Merck Sharp & Dohme LLC

Completed

Comparative Study of Immunogenicity and Safety of a 2-dose Regimen of ProQuad® Manufactured With rHA (V221-038)

Measles | Rubella | Mumps | Varicella
Merck Sharp & Dohme LLC

Completed

V221 Concomitant Use Study With Pneumococcal Conjugate Vaccine (V221-019)

Measles | Rubella | Mumps | Varicella
PT Bio Farma

Completed

Reactogenicity and Protectivity Following Measles- Rubella (MR) Routine Immunization in Indonesian Infants and Children

Safety Issues | Immunogenicity

Indonesia
Micron Biomedical, Inc
Medical Research Council; Centers for Disease Control and Prevention

Completed

Measles and Rubella Vaccine Microneedle Patch Phase 1-2 Age De-escalation Trial

Healthy | Measles | Rubella | Vaccination

Gambia
Assistance Publique - Hôpitaux de Paris
Service de Bactériologie-Virologie-Hygiène, CHU Limoge; GO-CIC network (Réseau... and other collaborators

Completed

Search for the Measles Vaccine Virus Excretion in Breast Milk of Breastfeeding Women After Postpartum Vaccination With MMR (BREMEAVAC)

Measles | Rubella | Mumps

France
University Hospital, Grenoble

Not yet recruiting

Technical Feasibility Study of Ultrasound Muscle Imaging in Antenatal Ultrasound (FetUS)

Arthrogryposis Multiplex Congenita (AMC)
University Hospital, Grenoble

Recruiting

Pediatric and Adult Registry for Patients With ARThrogryposis (PARART)

Arthrogryposis Multiplex Congenita (AMC)

France
Assaf-Harofeh Medical Center

Unknown

The Influence of Probiotics on the Immunologic Response to Vaccinations in Infants

Measles | Rubella | Mumps | Immunity

Israel
Center for Research and Production of Vaccines...
Vietnam Military Medical University

Completed

Clinical Trial for Measles - Rubella Combined Vaccine (MRVAC) Produced by POLYVAC (Phase III)

Signs and Symptoms
University Hospital, Grenoble

Completed

Arthrogryposis Multiplex Congenita in Pediatric Age: Correlation Between MUScular MRI and Functional Evaluation (AMUSE)

Pediatric ALL | Arthrogryposis Multiplex Congenita | AMC-Arthrogryposis Multiplex Congenita

France
GlaxoSmithKline

Completed

Consistency Study of GlaxoSmithKline (GSK) Biologicals' MMR Vaccine (209762) (Priorix) Comparing Immunogenicity and Safety to Merck & Co., Inc.'s MMR Vaccine (M-M-R II), in Children 12 to 15 Months of Age

Measles | Rubella | Mumps

United States, Finland, Estonia, Spain, Mexico, Puerto Rico
GlaxoSmithKline

Completed

Assess GSK Biologicals' MMR Vaccine (Priorix) When Given to Healthy Children at the Age of 12 to 18 Months in Singapore.

Measles | Rubella | Mumps
The Immunobiological Technology Institute (Bio-Manguinhos)...

Not yet recruiting

Immunity Duration Study Eight Years After Vaccination of Children 12 to 23 Months With the Triple Viral Vaccine (Measles, Mumps and Rubella)

Measles Vaccine
Insel Gruppe AG, University Hospital Bern
Swiss National Science Foundation

Completed

Effect of Phosphodiesterase-5 Inhibition With Tadalafil on SystEmic Right VEntricular Size and Function (SERVE)

Heart Defects, Congenital | Transposition of Great Vessels With Ventricular Inversion

Switzerland, Austria
Assistance Publique - Hôpitaux de Paris
Ministry of Health, France

Not yet recruiting

Cardiac Resynchronization Therapy in Adult Congenital Heart Disease With Systemic Right Ventricle: RIGHT-CRT (RIGHT-CRT)

Congenital Heart Disease | Transposition of Great Vessels | Congenitally Corrected Transposition of the Great Arteries | Systemic Right Ventricle | Heart Failure Congenital

France
Centers for Disease Control and Prevention, China
Beijing Tiantan Biological Products Co., Ltd.

Completed

Study on Immunization Schedule of Beijing Tiantan Biological's Measles-mumps-rubella(MMR) Vaccine

Measles | Rubella | Mumps | Adverse Event Following Immunisation

China
MedImmune LLC
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Trial to Assess Safety, Efficacy, Tolerability and Immunogenicity of Influenza Virus Vaccine, Liquid Formulation (CAIV-T), Administered Concomitantly With a Combination Live, Attenuated, Mumps, Measles, and Rubella Vaccine in Healthy Children Aged 11 - 24 Months

Influenza

Singapore
University of British Columbia

Recruiting

Global Hip Dysplasia Registry (GHDR)

Hip Dislocation, Congenital | Congenital Hip Dysplasia | Congenital Dysplasia of the Hip | Congenital Hip Dislocation | Hip Dysplasia, Congenital, Nonsyndromic | Congenital Hip Displacement | Dislocation Of Hip, Congenital | Dislocation, Congenital Hip | Displacement, Congenital Hip | Dysplasia, Congenital... and other conditions

Canada
Sri Edupuganti, MD MPH
Merck Sharp & Dohme LLC

Completed

Measles, Mumps, and Rubella (MMR) Immunity in College Students

Measles | Rubella | Mumps

United States
GlaxoSmithKline
Parexel

Completed

Immunogenicity and Safety of GSK Biologicals' Combined Measles-mumps-rubella Vaccine in Volunteers, Seven Years of Age and Older

Measles | Rubella | Mumps

United States, Slovakia, Estonia
The Immunobiological Technology Institute (Bio-Manguinhos)...

Completed

Comparative Study of the Immunogenicity of MMR (Measles, Mumps and Rubella) Single Dose and Multidose Presentations (MMR)

Measles | Rubella | Mumps

Brazil
Merck Sharp & Dohme LLC

Completed

A Study of An Approved Vaccine at Mumps Expiry Potency in Healthy Children 12 to 18 Months of Age (V205C-007)(COMPLETED)

Measles | Rubella | Mumps | Varicella
University of Zurich
Merck Sharp & Dohme LLC

Recruiting

Immunity in Persons Fully Vaccinated Against Measles, Mumps and Rubella and Responses to Booster Vaccination (MIPS)

Measles | Rubella | Mumps

Switzerland
GlaxoSmithKline

Completed

Immunogenicity and Safety Study of GSK Biologicals' Candidate Malaria Vaccine Given at 6, 7.5 and 9 Months of Age in Co-administration With Measles, Rubella and Yellow Fever (YF) Vaccines Followed by a Booster of the Malaria Vaccine.

Malaria | Malaria Vaccines

Ghana
GlaxoSmithKline

Completed

Evaluate Vaccine Against Chickenpox and a Combined Vaccine Against 4 Viral Childhood Diseases: Measles, Mumps, Rubella and Chickenpox

Varicella | Chickenpox Vaccines

Russian Federation, Romania, Czechia, Slovakia, Italy, Sweden, Poland, Greece, Norway, Lithuania
Alba Maria Ropero
Centers for Disease Control and Prevention; Ministry of Public Health, Argentina

Completed

Immunogenicity of Co-administered Yellow Fever and Measles, Mumps, and Rubella (MMR) Vaccines

Vaccine Response Impaired

Argentina
The Immunobiological Technology Institute (Bio-Manguinhos)...

Completed

Serological Study in Children 12 to 23 Months Vaccinated With MMR (Measles, Mumps and Rubella)

Measles | Rubella | Mumps

Brazil
Sanofi Pasteur, a Sanofi Company

Completed

Study of a Pneumococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Toddlers and Infants

Pertussis Immunisation | Diphtheria Immunisation | Tetanus Immunisation | Pneumococcal Immunisation | Hepatitis B Immunisation | Haemophilus Influenzae Type b Immunisation | Polio Immunisation | Measles Immunisation | Rubella Immunisation | Varicella Immunisation | Mumps Immunisation

United States, Canada, Honduras, Puerto Rico
The Immunobiological Technology Institute (Bio-Manguinhos)...
GlaxoSmithKline

Completed

Study of Immunogenicity, Reactogenicity and Safety of the Combined Measles, Mumps and Rubella Vaccine Produced by Bio-Manguinhos/Fiocruz in Children 12-15 Months of Age, Followed by Tetraviral Vaccine in Children 15-18 Months.

Measles | Rubella | Mumps | Varicella

Brazil

Clinical Trials on Congenital+Rubella

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ireland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations